| INTRODUCTION
Protein phosphorylation by protein kinases plays essential roles in signaling pathways that regulate normal cell function, and kinase dysregulation leads to various pathologies, including cancer. Cancerrelated signaling by kinases has been well analyzed, but information relevant to the role of serine/threonine phosphoprotein phosphatases (PPP) in tumor formation remains limited. 1, 2 Protein phosphatase 6 (PP6) is a PPP consisting of a catalytic (Ppp6c) and regulatory subunits. 3 In mammalian cell lines, diverse phenotypes seen following siRNA-based Ppp6c depletion suggest that PP6 regulates mitosis by dephosphorylating aurora kinase A, 4 activates DNA-PK to sensitize cells to ionizing radiation, 5, 6 and is required for homology-directed double strand repair. 7 PP6 also regulates NFjB signaling by suppressing IkBe degradation in response to TNFa 8 and inactivates TAK1. 9 Recent DNA sequencing screens relevant to human cancer highlight the importance of PP6 in tumorigenesis. Somatic mutation of
Ppp6c is reported in approximately 10% of malignant melanomas, 10, 11 and approximately 20% of skin basal cell carcinomas. 12 In melanoma samples, Ppp6c mutations are often accompanied by loss of heterozygosity (LOH) and occur in genomic hot-spots associated with protein function or stability, 13 suggesting that Ppp6c loss is associated with tumor formation. Another important finding is that melanoma tissues harboring Ppp6c mutations constitute a different subset than those containing mutations in pTEN, a major melanoma suppressor, although both subtypes contain B-raf or N-ras mutations. 10 We previously assessed Ppp6c function in vivo using a skin carcinogenesis mouse model engineered by Hayashi et al 14 .
Given that
Ppp6c null mice exhibit early embryonic lethality, 15 that group engineered mice homozygous for a loxP-targeted allele on chromosome 4, which, when crossed with K14Cre tam mice, undergo Credependent Ppp6c deletion in cytokeratin 14-positive keratinocytes. 14 In normal skin, a single treatment with 7,12-dimethylbenz(a)anthracene (DMBA) does not produce papillomas in the absence of tumor promoters 16 ; however, we subsequently reported that a single DMBA application was sufficient to generate papillomas in Ppp6c-deficient skin, suggesting that Ppp6c loss predisposes cells to DMBA-induced papilloma formation. 14 Using the same mice, Kato et al 17 reporte that Ppp6c loss in mouse keratinocytes increases susceptibility to UVB-induced carcinogenesis. These latter 2 studies were the first to report that Ppp6c loss-of-function acts as a tumor promoter in mice.
K-ras activating mutations occur in one-third of all human cancers. 18 Although oncogenic K-ras functions in tumor initiation and progression, the use of mouse models to define how K-ras targets and activates downstream effectors has been limited. Here, we examined the effect of Ppp6c loss on K-ras-induced proliferation in the context of keratinocyte tumorigenesis. We report that Ppp6c deficiency enhances K-ras
G12D
-dependent tumor promotion. 
| MATERIALS AND METHODS

| Generation of mice with inducible
| PCR genotype analysis
To confirm excision of the loxP-flanked transcription stop cassette from the LSL-K-ras G12D allele in DNA from mice treated with 4HT, we used the following primers: (i) 5 0 -GTCTTTCCCCAGCACAGTGC- Figure 1A ). Cre-mediated deletion of the Ppp6c floxed allele was confirmed as described, 14 using Figure 1A ).
| Histology and immunohistochemistry
After perfusion with PBS to remove blood, lip tissue from tumor and control mice was dissected, fixed overnight in buffered 3.7% formalin at room temperature, transferred to sequential 70%, 80%, 90%
and 100% methanol, and embedded in paraffin. Sections were stained with H&E and examined microscopically by 2 pathologists.
Images were acquired using an Olympus BX53 microscope (Tokyo, Japan Basel, Switzerland).
| Statistical analysis
Kaplan-Meier survival curves and corresponding statistical analysis, as well as log-rank tests, were done using Prism version 7 (GraphPad Software, San Diego, California, USA). Other statistical significance was determined using Student's t test. P < .05 served as the cut-off for significance.
| RESULTS
| Development of keratinocyte-specific
K-ras G12D -expressing and Ppp6c-deficient mice
To assess the effects of PP6 loss on activated K-ras-induced longer than a year without overt defects, as described. Because AKT activates the cell cycle, 20 enhanced cell cycle progression seen in doubly-mutant lip skin tissues ( Figure 3C ) could be attributable to activated AKT.
We next examined the effect of Ppp6c deficiency on DNA repair, as it is reported that activated K-ras induces DNA breaks by inducing reactive oxygen species, 21 and PP6 plays a key role in homology-directed repair. 22 To monitor double-strand breaks (DSB) in epidermis, we evaluated the expression of cH2AX, a DSB marker.
As shown in Figure 4 , by 12 days after 4HT treatment, lip tissues of an AKT target and key effector of AKT signaling. 20 As shown in Figure 5 , phosphorylation of GSK3 at S21/9 was upregulated in almost all epidermal tissues in doubly-mutant mice.
| DISCUSSION
The purpose of this study was to examine the effect of Staining was evaluated in cH2AX-positive epidermal cells of 1-mm width. Data are means AE SE derived from 4 areas in independent samples. *P < .05. n.s., non-significant overexpression of mutant N-ras increases the frequency of DNA damage, leading to increased frequency of error-prone repair of DSB by nonhomologous end-joining. 25 Our findings suggest that similar mechanisms may operate in mouse skin. Figure 4B shows that mutated Kras-induced epidermal cH2AX accumulation, an effect significantly enhanced by Ppp6c deficiency, suggesting perturbed DNA stability in doubly mutant tissues. Given reports that PP6 functions in homology directed repair via a DNA-PK-dependent mechanism 5, 6 these data strongly suggest that K-ras-induced DNA breaks are not fully repaired in conditions of PP6 deficiency, supporting the idea that Ppp6c deficiency accelerates K-ras
G12D
-initiated genomic instability.
K-ras is frequently mutated in pancreatic ductal adenocarcinoma (PDA) (approximately 90%), colon and rectal carcinoma (CRC) (approximately 50%) and lung adenocarcinoma (LAC) (approximately 25%). 18 Numerous anti-Ras reagents have been devised as treatment for PDA, CRC or LAC, but successful therapies remain elusive. 18 It has been shown that in some pathologies, Ppp6c is downregulated epigenetically. For example, NF-jB-induced miR-31 downregulates Ppp6c and promotes epidermis hyperproliferation in psoriasis.
26
Ppp6c downregulation by miR-373 may explain why miR-373 expression can promote proliferation of hepatocellular carcinoma cells. 27 Thus, loss of Ppp6c function by upregulation of miRNA that bind to the Ppp6c 3 0 UTR may accelerate formation of K-ras primed PDA, CRC and LAC.
In conclusion, we have defined synergy between Ppp6c defi- 
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